Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-734-6 | CAS number: 162492-01-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 May - 23 Nov 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- adopted in 2014
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Schwabach, Germany
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Hexamethylene diisocyanate, trimers, reaction products with 2-hydroxyethyl acrylate
- EC Number:
- 500-734-6
- EC Name:
- Hexamethylene diisocyanate, trimers, reaction products with 2-hydroxyethyl acrylate
- Cas Number:
- 162492-01-5
- Molecular formula:
- C39 H60 N6 O15
- IUPAC Name:
- Hexamethylene diisocyanate, trimers, reaction products with 2-hydroxyethyl acrylate
Constituent 1
Method
- Target gene:
- Not applicable
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: ATCC, CCL-93
- Suitability of cells: The cells were chosen because of their stable karyotype and their low spontaneous induction rate of micronucleus formation under standardized culture conditions.
- Methods for maintenance in cell culture: Thawed cultures were set up in 75 cm² cell culture plastic flasks at 37°C in 5% CO2 atmosphere. 5x10E5 cells per flask were seeded in 15 mL of minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS) and subcultures were made every 3 - 4 days.
MEDIA USED
- Type and identity of media including CO2 concentration: MEM supplemented with 10% FBS, 100 U/100 µg/mL penicillin/streptomycin solution, 2 mM L-glutamine, 2.5 µg/mL amphotericin and 25 mM HEPES; 5% CO2
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/ beta-naphthoflavone
- Test concentrations with justification for top dose:
- Pre-experiment: with and without metabolic activation: 7.8, 15.6, 31.3, 62.5, 125, 250, 500, 1000, 1500 and 2000 µg/mL
Experiment I without metabolic activation: 0.025, 0.05, 0.10, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5 and 10 µg/mL
Experiment I with metabolic activation: 25, 50, 100, 120, 140, 160, 180, 200, 225 and 250 µg/mL
Experiment II: without metabolic activation: 0.5, 1.0, 2.0, 3.0, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0 and 7.5 µg/mL
A concentration of 2000 µg/mL was used in the pre-experiment since this is the highest recommended dose according to the guideline used. The concentrations used in the main experiments were based on cytotoxicity of the test item observed in the pre-experiment. - Vehicle / solvent:
- - Vehicle/solvent used: DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- other: colchicin
- Remarks:
- - S9: ethylmethanesulphonate (1200 µg/mL in experiment I, 900 µg/mL in experiment II), colchicin (1.5 µg/mL in experiment I, 0.16 µg/mL in experiment II) + S9: cyclophosphamide (2.5 µg/mL in experiment I)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: approximately 50000 cells per 25 cm² cell culture flask
DURATION
- Preincubation period: approximately 48 h
- Exposure duration: 4 and 24 h
- Fixation time (start of exposure up to fixation or harvest of cells): 24 h
SPINDLE INHIBITOR (cytogenetic assays): cytocalasin B (final concentration: 1.5 µg/mL)
STAIN (for cytogenetic assays): acridine orange solution
NUMBER OF REPLICATIONS: Duplicate cultures for every concentration/ control (except for the pre-experiment).
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: At the end of the cultivation, the complete culture medium was removed. Subsequently, cells were trypsinated and resuspended in medium. The cultures were transferred into tubes and incubated with hypotonic solution (0.4% KCl) for some minutes at room temperature. Cells were then fixed with methanol + glacial acetic acid (3+1) and resuspended gently. The suspension was dropped onto clean glass slides, heat dried and stained with acridine orange.
NUMBER OF CELLS EVALUATED: at least 2000 binucleated cells per concentration (1000 binucleated cells per slide)
CRITERIA FOR MICRONUCLEUS IDENTIFICATION: clearly surrounded by a nuclear membrane, having an area of less than one-third that of the main nucleus, being located within the cytoplasm of the cell, not linked to the main nucleus via nucleoplasmic bridges; mononucleated and multinucleated cells and cells with more than six micronuclei were not considered
DETERMINATION OF CYTOTOXICITY
- Method: cytokinesis block proliferation index from 500 cells - Evaluation criteria:
- A test substance was considered positive in the micronucleus test if:
a) at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control
b) the increase is concentration-related in at least one experimental condition when evaluated with an appropriate trend test
c) any of the results are outside the distribution of the historical negative/solvent control data.
When all of these criteria are met, the test item is considered able to induce chromosome breaks and/or gain or loss in this test system. A test item is considered to be clearly negative if in all experimental conditions examined none of the criteria mentioned above are met. - Statistics:
- non-parametric chi²-test, p < 0.05
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 2.5 µg/mL and above (experiment I, -S9); at 200 µg/mL and above (experiment I, +S9); at 4.0 µg/mL and above (experiment II, -S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation of the test item was noted at concentrations of 125 µg/mL and above without metabolic activation and at concentrations of 250 µg/mL and above with metabolic activation.
CYTOKINESIS BLOCK (if used)
- Distribution of mono-, bi- and multi-nucleated cells: see tables 1 and 2
NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: see tables 1 and 2
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: see table 3
- Negative historical control data: see table 3
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: CBPI
Any other information on results incl. tables
Table 1 Results of experiment I (4 h treatment with and without metabolic activation, 24 h fixation period)
Test item |
Concentration [µg/mL] |
Cytostasis [%] |
Relative cell growth [%] |
Micronucleated cells frequency [%] |
|
without metabolic activation |
|||
Negative control |
0 |
6 |
94 |
0.95 |
Solvent control |
0 |
0 |
100 |
1.35 |
Test substance |
0.5 |
8 |
92 |
0.75 |
1.0 |
16 |
84 |
1.25 |
|
2.5 |
47 |
53 |
1.25 |
|
EMS |
1200 |
27 |
73 |
4.90 |
Colchicine |
1.5 |
22 |
78 |
2.60 |
|
with metabolic activation |
|||
Negative control |
0 |
13 |
87 |
1.10 |
Solvent control |
0 |
0 |
100 |
1.30 |
Test substance |
25 |
1 |
99 |
0.65 |
50 |
9 |
91 |
0.80 |
|
100 |
12 |
88 |
0.70 |
|
200 |
57 |
43 |
0.55 |
|
CPA |
2.5 |
49 |
51 |
4.25 |
Negative control = cell culture medium, solvent control = DMSO or ethanol 1% v/v in cell culture medium, positive controls = ethylmethanesulfonate (EMS; without metabolic activation), colchicine (without metabolic activation), cyclophosphamide (CPA; with metabolic activation)
Cytostasis [%] = 100 – Relative Cell Growth [%]
Relative Cell Growth [%] = 100 x ((CBPI(test conc) – 1) / (CBPI(control – 1))
CBPI = Cytokinesis Block Proliferation Indix = ((mononucleate cells x 1) + (binucleate cells x 2) + (multinucleate cells x 3) / total number of cells
Table 2 Results of experiment II (24 h treatment without metabolic activation)
Test item |
Concentration [µg/mL] |
Cytostasis [%] |
Relative cell growth [%] |
Micronucleated cells frequency [%] |
|
without metabolic activation |
|||
Negative control |
0 |
0 |
122 |
1.05 |
Solvent control |
0 |
0 |
100 |
1.10 |
Test substance |
2.0 |
10 |
90 |
0.83 |
4.0 |
40 |
60 |
1.30 |
|
6.0 |
60 |
40 |
1.25 |
|
EMS |
900 |
54 |
46 |
4.55 |
Colchicine |
0.16 |
15 |
85 |
4.60 |
Negative control = cell culture medium, solvent control = DMSO or ethanol 1% v/v in cell culture medium, positive controls = ethylmethanesulfonate (EMS; without metabolic activation), colchicine (without metabolic activation)
Cytostasis [%] = 100 – Relative Cell Growth [%]
Relative Cell Growth [%] = 100 x ((CBPI(test conc) – 1) / (CBPI(control – 1))
CBPI = Cytokinesis Block Proliferation Indix = ((mononucleate cells x 1) + (binucleate cells x 2) + (multinucleate cells x 3) / total number of cells
Table 3 Historical control data
|
Negative control |
Solvent Control |
Positive controls |
||||
|
Metabolic activation |
||||||
|
without |
with |
without |
with |
without (EMS) |
without (Colchicine) |
with (CPA) |
Mean |
0.91 |
1.07 |
0.88 |
1.03 |
4.19 |
4.21 |
4.00 |
SD |
0.29 |
0.38 |
0.22 |
0.46 |
1.42 |
2.63 |
1.59 |
RSD |
31.67 |
35.27 |
25.30 |
44.51 |
33.91 |
62.33 |
39.62 |
Min |
0.45 |
0.50 |
0.55 |
0.55 |
2.25 |
1.85 |
2.30 |
Max |
1.50 |
1.75 |
1.40 |
1.83 |
7.40 |
14.20 |
9.85 |
LCL |
0.34 |
0.31 |
0.43 |
0.11 |
1.35 |
0.00 |
0.00 |
UCL |
1.49 |
1.82 |
1.32 |
1.95 |
7.03 |
9.47 |
7.18 |
n |
39 |
22 |
11 |
6 |
39 |
39 |
22 |
Negative control = cell culture medium, solvent control = DMSO or ethanol 1% v/v in cell culture medium, positive controls = ethylmethanesulfonate (EMS; without metabolic activation), colchicine (without metabolic activation), cyclophosphamide (CPA; with metabolic activation)
Mean: mean number of micronucleated cells (%), SD: standard deviation, RSD: relative standard deviation (%), Min: minimum number of micronucleated cells, Max: maximum number of micronucleated cells, LCL: lower control limit (95%, mean-2SD), UCL: upper control limit (95%, mean+2SD), n: number of assays
Applicant's summary and conclusion
- Conclusions:
- Based on the results of the conducted study the test substance did not exhibit mutagenic properties in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.